Shares of Bristol-Myers Squibb Have Risen Above Previous 52-Week High Financial News Network Online The Company's products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders. Bristol-Myers Squibb (NYSE:BMY) defies analysts with a current ... |
